Insights

Gathering insights about AM-Pharma…

Similar companies to AM-Pharma

AM-Pharma Tech Stack

AM-Pharma uses 8 technology products and services including jQuery CDN, Shopify, Google Font API, and more. Explore AM-Pharma's tech stack below.

jQuery CDN
Content Delivery Network
Shopify
E-commerce
Google Font API
Font Scripts
RSS
Miscellaneous
PHP
Programming Languages
MediaElement.js
Video Players
YouTube
Video Players
Nginx
Web Servers

Media & News

AM-Pharma hires Juliane Bernholz as Chief Executive Officer.
AM-Pharma also announced the appointment of Juliane Bernholz, Ph.D., as Chief Executive Officer.
Sep 25, 2023 | www.biospace.com
AM-Pharma hired Alexander Bastian as Vice President Value & Market Access on Nov 3rd '21.
AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced the appointment of Alexander Bastian as Vice President Value & Market Access, effective immediately.
Nov 03, 2021 | www.businesswire.com
AM-Pharma hired Lars R. Boesgaard as Chief Financial Officer on Sep 15th '21.
AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced the appointment of Lars R. Boesgaard as Chief Financial Officer (CFO), effective immediately.
Sep 15, 2021 | www.businesswire.com
Pfizer, Inc. acquired AM-Pharma for $87.5M on Jan 1st '18.
Pfizer declined its option to fully acquire AM-Pharma in 2018, after having dished out $87.5 million for a minority stake in 2015.
Sep 08, 2021 | www.fiercebiotech.com
AM-Pharma hired Mark Altmeyer as Chairman of Supervisory Board on Jul 6th '21.
AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced the appointment of Mark Altmeyer, MBA, as Chairman of its Supervisory Board.
Jul 06, 2021 | www.businesswire.com
KBI Biopharma Inc. partnered with AM-Pharma on Jun 1st '21.
Durham-based KBI Biopharma announced Thursday that it had entered into a commercial manufacturing agreement with AM-Pharma for its recombinant human Alkaline Phosphatase (recAP) program intended to treat acute kidney injury associated with sepsis.
Jun 18, 2021 | www.bizjournals.com
AM-Pharma hired Martijn Negen as Vice President for Commercial Strategy on Jun 16th '21.
AM-Pharma B.V., an emerging leader focused on developing therapeutics for severe medical conditions, today announced the appointment of Martijn Negen, MSc, MBA, as Vice President for Commercial Strategy.
Jun 16, 2021 | ysioscapital.com

AM-Pharma's Email Address Formats

AM-Pharma uses at least 1 format(s):

AM-Pharma Email Formats	Example	Percentage
f.last@am-pharma.com	J.Doe@am-pharma.com	82%
first-last@am-pharma.com	John-Doe@am-pharma.com	7%
firmlast@am-pharma.com	JohMDoe@am-pharma.com	6%
last@am-pharma.com	Doe@am-pharma.com	5%

Frequently Asked Questions

Where is AM-Pharma's headquarters located?

AM-Pharma's main headquarters is located at Stadsplateau 6 Utrecht, 3521 AZ NL. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is AM-Pharma's phone number?

You can contact AM-Pharma's main corporate office by phone at +31-30-228-9222. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AM-Pharma's official website and social media links?

AM-Pharma's official website is am-pharma.com and has social profiles on LinkedIn.

How much revenue does AM-Pharma generate?

As of February 2024, AM-Pharma's annual revenue reached $3.8M.

What is AM-Pharma's SIC code NAICS code?

AM-Pharma's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AM-Pharma have currently?

As of February 2024, AM-Pharma has approximately 21 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: J. B.Vice President Finance: P. V.Vice President Global Commercial Strategy & Business Development: M. N. M.. Explore AM-Pharma's employee directory with LeadIQ.

What industry does AM-Pharma belong to?

AM-Pharma operates in the Biotechnology Research industry.

What technology does AM-Pharma use?

AM-Pharma's tech stack includes jQuery CDNShopifyGoogle Font APIRSSPHPMediaElement.jsYouTubeNginx.

What is AM-Pharma's email format?

AM-Pharma's email format typically follows the pattern of . Find more AM-Pharma email formats with LeadIQ.

When was AM-Pharma founded?

AM-Pharma was founded in 2002.

AM-Pharma

Biotechnology ResearchUtrecht, Netherlands11-50 Employees

AM-Pharma BV is a biopharmaceutical company developing recombinant Alkaline Phosphatase for clinical use.

Company Overview

Headquarters: Stadsplateau 6 Utrecht, 3521 AZ NL
Phone number: +31-30-228-9222
Website: am-pharma.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2002
Employees: 11-50